Scarica l'app Stockscreener
52.88
2.70%
-1.47
Dopo l'orario di chiusura:
53.14
0.26
+0.49%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MRNA Giù?
Forum
Previsione
Precedente Chiudi:
$54.35
Aprire:
$58.08
Volume 24 ore:
24.04M
Relative Volume:
2.90
Capitalizzazione di mercato:
$20.98B
Reddito:
$2.23B
Utile/perdita netta:
$-3.19B
Rapporto P/E:
-6.4914
EPS:
-8.1462
Flusso di cassa netto:
$-1.60B
1 W Prestazione:
+11.80%
1M Prestazione:
+3.77%
6M Prestazione:
+100.23%
1 anno Prestazione:
+118.06%
Intervallo 1D:
$51.39
$59.48
Intervallo di 1 settimana:
$45.78
$59.48
Portata 52W:
$22.28
$59.55
Moderna Inc Stock (MRNA) Company Profile
Nome
Moderna Inc
Settore
Industria
Telefono
(617) 714-6500
Indirizzo
325 BINNEY STREET, CAMBRIDGE
Compare MRNA vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MRNA
Moderna Inc
|
52.88 | 21.57B | 2.23B | -3.19B | -1.60B | -8.1462 |
VRTX
Vertex Pharmaceuticals Inc
|
435.17 | 109.09B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
712.77 | 74.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
813.28 | 48.64B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
284.84 | 39.39B | 4.29B | 577.22M | 641.34M | 4.2086 |
ONC
Beone Medicines Ltd Adr
|
310.75 | 32.38B | 5.36B | 287.73M | 924.18M | 2.5229 |
Moderna Inc Stock (MRNA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-28 | Ripresa | Barclays | Equal Weight |
| 2026-01-07 | Ripresa | UBS | Neutral |
| 2025-12-12 | Iniziato | Jefferies | Hold |
| 2025-03-13 | Iniziato | Citigroup | Neutral |
| 2025-02-18 | Downgrade | Barclays | Overweight → Equal Weight |
| 2025-01-29 | Downgrade | Goldman | Buy → Neutral |
| 2024-12-18 | Downgrade | Argus | Buy → Hold |
| 2024-12-10 | Ripresa | BofA Securities | Underperform |
| 2024-11-19 | Iniziato | Berenberg | Hold |
| 2024-11-18 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-11-15 | Iniziato | Wolfe Research | Underperform |
| 2024-10-17 | Iniziato | Bernstein | Mkt Perform |
| 2024-09-13 | Downgrade | JP Morgan | Neutral → Underweight |
| 2024-09-13 | Downgrade | Jefferies | Buy → Hold |
| 2024-09-13 | Downgrade | Oppenheimer | Outperform → Perform |
| 2024-08-28 | Aggiornamento | HSBC Securities | Reduce → Hold |
| 2024-08-07 | Aggiornamento | Deutsche Bank | Sell → Hold |
| 2024-08-05 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-02-26 | Downgrade | HSBC Securities | Hold → Reduce |
| 2024-01-02 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2023-11-29 | Iniziato | Canaccord Genuity | Hold |
| 2023-11-03 | Aggiornamento | HSBC Securities | Reduce → Hold |
| 2023-11-02 | Downgrade | Deutsche Bank | Hold → Sell |
| 2023-08-04 | Downgrade | TD Cowen | Outperform → Market Perform |
| 2023-08-03 | Downgrade | Deutsche Bank | Buy → Hold |
| 2023-07-24 | Iniziato | William Blair | Mkt Perform |
| 2023-07-14 | Iniziato | HSBC Securities | Reduce |
| 2023-06-26 | Aggiornamento | UBS | Neutral → Buy |
| 2023-04-26 | Iniziato | Guggenheim | Neutral |
| 2023-03-13 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2023-03-02 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-02-24 | Downgrade | SVB Securities | Market Perform → Underperform |
| 2022-12-19 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-12-14 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2022-10-21 | Aggiornamento | SVB Leerink | Underperform → Mkt Perform |
| 2022-09-08 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2022-02-01 | Aggiornamento | Redburn | Sell → Neutral |
| 2022-01-26 | Aggiornamento | Deutsche Bank | Sell → Hold |
| 2022-01-21 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-01-21 | Iniziato | UBS | Neutral |
| 2021-12-07 | Iniziato | Cowen | Market Perform |
| 2021-11-09 | Iniziato | Wolfe Research | Outperform |
| 2021-10-22 | Iniziato | Deutsche Bank | Sell |
| 2021-10-15 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-08-06 | Downgrade | Oppenheimer | Outperform → Perform |
| 2021-08-06 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-07-15 | Reiterato | Jefferies | Hold |
| 2021-02-01 | Downgrade | BofA Securities | Neutral → Underperform |
| 2020-12-16 | Downgrade | Jefferies | Buy → Hold |
| 2020-12-16 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-09 | Downgrade | Needham | Buy → Hold |
| 2020-11-23 | Iniziato | Wells Fargo | Equal Weight |
| 2020-11-17 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2020-09-08 | Downgrade | SVB Leerink | Mkt Perform → Underperform |
| 2020-07-23 | Iniziato | SVB Leerink | Mkt Perform |
| 2020-07-20 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-07-13 | Iniziato | Jefferies | Buy |
| 2020-06-30 | Iniziato | Argus | Buy |
| 2020-06-08 | Iniziato | Barclays | Overweight |
| 2020-04-30 | Iniziato | BMO Capital Markets | Outperform |
| 2020-03-05 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-12-03 | Ripresa | BofA/Merrill | Buy |
| 2019-10-25 | Iniziato | ROTH Capital | Buy |
| 2019-04-05 | Iniziato | Chardan Capital Markets | Buy |
Mostra tutto
Moderna Inc Borsa (MRNA) Ultime notizie
Nvidia, Lumentum, Intel, Micron, Qualcomm, Tesla, Moderna, Circle Internet, and More Movers - Barron's
Key facts: Moderna mRNA hantavirus vaccines; stock up, $74 target - TradingView
Moderna Stock Is Surging on Hantavirus Threats. Its Chart Offers a Harsh Dose of Reality. - Barchart.com
Moderna Stock Loses Steam. Hantavirus Trade Fizzles as Officials Dismiss Pandemic Risk. - Barron's
Moderna Shares Have Rallied. Why the Stock Could Climb Another 30%. - Barron's
Moderna (MRNA) Shares Rise Amid Hantavirus Treatment Evaluation - GuruFocus
Moderna stock (US60770K1034): Shares rally 12% on hantavirus vaccine research - AD HOC NEWS
Moderna shares jump as it reveals it has been researching vaccines against hantaviruses - Yahoo Finance
Moderna (MRNA) Develops Hantavirus Vaccine Amid Low Pandemic Thr - GuruFocus
Moderna’s stock has rallied on hantavirus research that is ‘early-stage’ in nature - MarketWatch
Moderna (MRNA) Stock Rises Amid Hantavirus Outbreak Concerns - GuruFocus
Best Biotech Stocks To Follow NowMay 11th - MarketBeat
Moderna Stock Is Up 6% Today: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax? - 24/7 Wall St.
Moderna shares extend gains as hantavirus vaccine work draws attention - Proactive financial news
Moderna stock pops as investors zero in on hantavirus work following the deadly cruise ship outlook - Business Insider
Moderna Says It's Researching a Hantavirus Vaccine. The Drugmaker's Stock Is Surging. - Investopedia
Moderna stock soars as hantavirus fears spark outbreak trade - TradingView
Moderna stock (US60770K1034): Q1 earnings beat on revenue, EPS miss sparks gains - AD HOC NEWS
Moderna stock extends gains on hantavirus research - Yahoo Finance
MRNA Stock Jumps As Earnings Beat Fuels Pipeline Hype - timothysykes.com
Stocks to Watch: Moderna, Intel, MidCap Financial -- WSJ - Moomoo
Stock market today: S&P 500, Dow futures fall as Trump rejects 'totally unacceptable' Iran peace proposal—Micron Technologies, Moderna in focus - MSN
Premarket Winners: Moderna (MRNA), Intel (INTC), and Micron (MU) Rally on Monday - Blockonomi
Stock Market Today: Dow, Nasdaq Futures Fall As Trump Rejects 'Totally Unacceptable' Iran Peace Proposal—Micron, Moderna In Focus (UPDATED) - Benzinga
Today’s Market Movers: Moderna, Intel, and Micron Lead Premarket Gains - CoinCentral
Moderna (MRNA) Stock Jumps After Hantavirus Outbreak Sparks Biotech Rally - CoinCentral
Moderna stock surges on hantavirus vaccine, flu trial data - Yahoo Finance
S&P 500 Futures Steady in Premarket Trading; Everpure, Moderna Lead - Barron's
Moderna Updates Bylaws and Confirms Governance Leadership - TipRanks
Moderna (MRNA) Shares Surge After U.S. Passenger Tests Positive for Hantavirus - Yahoo Finance
Moderna (MRNA) amends bylaws and details 2026 stockholder voting outcomes - Stock Titan
Moderna Shares Jump 8% After Company Flags Early Hantavirus Vaccine Work - Moomoo
Mitsubishi UFJ Asset Management Co. Ltd. Sells 24,187 Shares of Moderna, Inc. $MRNA - MarketBeat
Moderna shares jump 8% after U.S. national tests positive for hantavirus - Investing.com Canada
Moderna Stock Gets Fresh Hantavirus Jolt As Cruise-Ship Outbreak Widens - TechStock²
Moderna (MRNA) Sees Gains Amid Market Uncertainty - GuruFocus
Avoiding Lag: Real-Time Signals in (MRNA) Movement - Stock Traders Daily
Top Biotech Stocks To ConsiderMay 10th - MarketBeat
Moderna Stock Jumps As Q1 Beat Fuels Pipeline Hopes - timothysykes.com
Hantavirus Appears Sporadically, Is Now the Opportunity to Buy Vaccine Concept Stock Moderna? - TradingKey
Moderna reports Q1 loss, stock jumps on strong international sales - MSN
Moderna Inc. stock (US60770K1034): Shares surge on positive flu vaccine data and regulatory filings - AD HOC NEWS
Biotech Stocks To Watch NowMay 9th - MarketBeat
Moderna Stock Surges on Hantavirus Vaccine Research as MRNA Investors Eye Flu and Cancer Pipeline - TechStock²
Moderna Stock Jumps As Q1 Beat Fuels Vaccine And Oncology Hopes - timothysykes.com
MRNA SEC FilingsModerna 10-K, 10-Q, 8-K Forms - Stock Titan
MRNA stock clocks best day in over two months on early-stage hantavirus vaccine research - MSN
MRNA Stock Clocks Best Day In Over Two Months On Early-Stage Hantavirus Vaccine Research - Stocktwits
[Form 4] Moderna, Inc. Insider Trading Activity - Stock Titan
Moderna (MRNA) Gains Attention Amid Rising Virus Concerns - GuruFocus
MRNA Stock Alert: Moderna Surges on Hantavirus Vaccine Hopes - Yahoo Finance
Moderna Inc Azioni (MRNA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Moderna Inc Azioni (MRNA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Hussain Abbas | Director |
May 01 '26 |
Sale |
46.63 |
5,682 |
264,952 |
12,066 |
2.51%
0.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):